SCHEMBL7879728

SCHEMBL7879728

CNC(N)=NC(=O)c1cc2ccc(OCCN)cc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 5/20 0.43
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
PDGFRB P09619 5/20 0.39
PDGFRA P16234 5/20 0.39
ALOX15 P16050 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RXFP1 Q9HBX9 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
XDH P47989 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7879744 0.94 FLT3 (0.41) FLT3DRD2DRD3PDGFRBPDGFRA
Hydrochloric Acid SCHEMBL8628104 0.94 FLT3 (0.41) FLT3DRD2DRD3PDGFRBPDGFRA
Hydrochloric Acid SCHEMBL7881414 0.90 FLT3 (0.42) FLT3DRD2DRD3PDGFRBPDGFRA
SCHEMBL7877764 0.88 FLT3 (0.58) FLT3DRD2DRD3PDGFRBPDGFRA
SCHEMBL7881223 0.87 PDGFRB (0.53) FLT3DRD2DRD3PDGFRBPDGFRA
Hydrochloric Acid SCHEMBL7877957 0.87 KMT2A (0.40) FLT3PDGFRBPDGFRAALOX15KMT2A
Hydrochloric Acid SCHEMBL8626860 0.87 KMT2A (0.40) FLT3PDGFRBPDGFRAALOX15KMT2A
SCHEMBL7879928 0.86 FLT3 (0.46) FLT3PDGFRBPDGFRAKMT2A
Hydrochloric Acid SCHEMBL7884837 0.86 MEN1 (0.42) FLT3PDGFRBPDGFRAALOX15KMT2A
Hydrochloric Acid SCHEMBL7873268 0.86 NPC1 (0.49) FLT3PDGFRBPDGFRAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1051301-C Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 2000-04-12 CN disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed